POZEN, Inc. (NASDAQ:POZN)
CAPS Rating:
A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.
RSS Headlines
Fool UK
Recs
Article from Zacks Biotech Guy - Jason Napodano - trying a strategy where I set 10% stops on all these and let the winners run.